EW - BofA upgrades Edwards to buy says double-digit growth is back
2024-03-07 14:12:00 ET
More on Edwards Lifesciences
- Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
- Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript
- Edward Lifesciences: Still Not A Buy But Getting Closer
- Edwards Lifesciences Non-GAAP EPS of $0.64 in-line, revenue of $1.53B beats by $30M
- Edwards Lifesciences Q4 2023 Earnings Preview